News from NORD

NORD and Other Patient Organizations Oppose Short-Term, Limited-Duration Health Plans


 

NORD has joined several other patient organizations in voicing opposition to proposed expansion of short-term, limited-duration health plans. NORD and its advocacy partners believe that expanding these plans would destabilize the insurance marketplace and increase premiums for those who are in the greatest need of care. For information, view the coalition letter to Congress here and letter to the Administration here.

Recommended Reading

Osteogenesis Imperfecta Foundation (OIF)
MDedge Family Medicine
FDA approves rituximab for treating pemphigus vulgaris
MDedge Family Medicine
FDA approves Epidiolex for Lennox-Gastaut syndrome and Dravet syndrome
MDedge Family Medicine
Oral drug seen preventing angioedema attacks
MDedge Family Medicine
Study supports meningococcal B vaccine in children with rare diseases
MDedge Family Medicine
Register Now for NORD’s Rare Impact Awards Celebration
MDedge Family Medicine
2018 Marks 35th Anniversary of NORD and the Orphan Drug Act
MDedge Family Medicine
RFPs Available for the Study of Three Rare Diseases
MDedge Family Medicine
More Than 100 Patient Organizations Join NORD in Supporting the RARE Act
MDedge Family Medicine
Medical Nutrition Equity Act Capitol Hill Day Planned for June 1
MDedge Family Medicine